Bio2Brain - Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system
diseases: A design-based approach for efficient drug delivery systems
The Bio2Brain project is an EU-funded project that launched in January 2021.
The aim of the Bio2Brain network is the development of a research and training program to train young scientists in innovating novel technologies to deliver biopharmaceuticals efficiently from the nose to the brain. It thereby offers a unique opportunity to 13 early career researchers to develop new paradigms and treatments in neurological diseases. Bio2Brain will create the fundament for the future transfer of the developed technologies for a later clinical development and GMP manufacturing.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956977.
Company Details
- Founded
- -
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://bio2brain.eu/
Bio2brain Questions
Bio2Brain's website is https://bio2brain.eu/
Bio2Brain's LinkedIn profile is https://www.linkedin.com/company/bio2brain
Bio2Brain's industry is
Research Services
Bio2Brain's top competitors are
Beiter Formenbau,
Lens - European Laboratory For Non-Linear Spectroscopy,
Greenx3,
Traumwerk Saarland,
Mybiotech Gmbh,
Institute Of Systems Biotechnology,
Abbvie,
Fraunhofer Institute For Interfacial Engineering And Biotechnology,
Radboudumc Postdoc Council,
Mip Pharma Group.
Bio2Brain's categories are Research Services
Bio2Brain's founding year is 2021
